Literature DB >> 29582468

Let-7c restores radiosensitivity and chemosensitivity and impairs stemness in oral cancer cells through inhibiting interleukin-8.

Chih-Yu Peng1,2, Tung-Yuan Wang1, Shiuan-Shinn Lee3, Pei-Ling Hsieh4, Yi-Wen Liao1, Lo-Lin Tsai5,6, Chih-Yuan Fang5,6, Cheng-Chia Yu1,2,4, Ching-Shui Hsieh7.   

Abstract

BACKGROUND: The let-7 family of microRNAs has been considered as tumor suppressors in various cancers; however, the role of let-7c in oral squamous cell carcinoma has not been determined yet.
METHODS: In this study, phenotypical behaviors and the radio/chemoresistance were examined subsequent to overexpression of let-7c. In addition, the expression of let-7c in cancer stem cells (CSCs) was evaluated and the effect of let-7c on stemness characteristics was assessed. Also, luciferase activity assays were performed to test whether interleukin (IL)-8 was a putative target of let-7c.
RESULTS: Our results confirmed that the expression of let-7c in CSCs was reduced, while overexpression of let-7c attenuated the oncogenicity. Moreover, ectopic expression of let-7c in CSCs downregulated the stemness hallmarks and the radio/chemoresistance. Expression and secretion of IL-8 in oral CSCs were both reduced following overexpression of let-7c. Besides, the inhibitory effect of let-7c on various stemness phenotypes was reverted by IL-8, indicating that lower expression of let-7c may confer higher cancer stemness through a failure to downregulate IL-8.
CONCLUSION: These findings revealed the significance of let-7c in the contribution of oral cancer stemness and radio/chemoresistance. Targeting let-7c and its downstream IL-8 may be beneficial to prevent cancer recurrence and metastasis of oral squamous cell carcinoma.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  cancer stemness; interleukin-8; let-7c; oral squamous cell carcinomas; radio/chemoresistance

Mesh:

Substances:

Year:  2018        PMID: 29582468     DOI: 10.1111/jop.12711

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  7 in total

Review 1.  Therapeutic targeting of the crosstalk between cancer-associated fibroblasts and cancer stem cells.

Authors:  Tu-Xiong Huang; Xin-Yuan Guan; Li Fu
Journal:  Am J Cancer Res       Date:  2019-09-01       Impact factor: 6.166

Review 2.  The interplay of cytokine signaling and non-coding RNAs in head and neck squamous cell carcinoma pathobiology.

Authors:  Vivek Sharma
Journal:  Mol Biol Rep       Date:  2022-07-24       Impact factor: 2.742

Review 3.  Role of miRNA-Regulated Cancer Stem Cells in the Pathogenesis of Human Malignancies.

Authors:  Abdul Q Khan; Eiman I Ahmed; Noor R Elareer; Kulsoom Junejo; Martin Steinhoff; Shahab Uddin
Journal:  Cells       Date:  2019-08-05       Impact factor: 6.600

Review 4.  MicroRNAs as Theranostics Targets in Oral Carcinoma Stem Cells.

Authors:  Pei-Ling Hsieh; Yi-Wen Liao; Martin Pichler; Cheng-Chia Yu
Journal:  Cancers (Basel)       Date:  2020-02-03       Impact factor: 6.639

5.  pERK-mediated IL8 secretion can enhance the migration, invasion, and cisplatin resistance of CD10-positive oral cancer cells.

Authors:  Yinfei Pu; Qingxiang Li; Yifei Wang; Le Xu; Qiao Qiao; Yuxing Guo; Chuanbin Guo
Journal:  BMC Cancer       Date:  2021-12-01       Impact factor: 4.430

Review 6.  Promising Biomarkers in Head and Neck Cancer: The Most Clinically Important miRNAs.

Authors:  Arsinoe C Thomaidou; Panagiota Batsaki; Maria Adamaki; Maria Goulielmaki; Constantin N Baxevanis; Vassilis Zoumpourlis; Sotirios P Fortis
Journal:  Int J Mol Sci       Date:  2022-07-26       Impact factor: 6.208

Review 7.  Mesenchymal stem cell-derived exosomes as new tools for delivery of miRNAs in the treatment of cancer.

Authors:  Aysegul Dalmizrak; Ozlem Dalmizrak
Journal:  Front Bioeng Biotechnol       Date:  2022-09-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.